Emergency icon Important Updates

Lisa Yerian, MD

Lisa Yerian, MD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Title Executive Vice President and Chief Clinical and Operational Improvement Officer
Department Executive Board Office
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Locations
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus

Appointment:
216.445.7446
Desk:
216.445.7446
Fax:
216.444.8258

Additional Locations

Pathology

Cleveland Clinic Main Campus

9500 Euclid Avenue
Cleveland, OH 44195
Directions

Appointment:
216.445.7446
Desk:
216.445.7446
Fax:
216.444.8258

Pathology

Avon Hospital

33300 Cleveland Clinic Blvd
Avon, OH 44011
Directions

Appointment:
216.445.7446
Desk:
216.445.7446
Fax:
216.444.8258
Specialties & Treatments

Treatment & Services

  • Histologic Diagnostics
View all 1 Treatment & Services +
Insurance

Insurance

Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans
Biography

About Lisa Yerian, MD

Lisa Yerian is Executive Vice President and Chief Clinical and Operational Improvement Officer at Cleveland Clinic. In this role, she leads more than one thousand caregivers in building an improvement culture and driving strategic improvements in safety, quality, patient experience, continuous improvement and patient access throughout Cleveland Clinic.  

Previously, Dr. Yerian was Chief Improvement Officer at Cleveland Clinic before becoming the Clinic’s Interim Chief Clinical Transformation Officer in July 2023. She has also served as Director of Liver Pathology and Section Head of Surgical Pathology at Cleveland Clinic and is a former member of the Board of Governors and Vice Chair of Professional Staff Affairs. 

Dr. Yerian graduated from the University of Chicago-Pritzker School of Medicine. She completed residency in anatomic pathology and fellowship in gastrointestinal and liver pathology also at the University of Chicago-Pritzker School of Medicine. Dr. Yerian also completed the Harvard Business School Program for Leadership Development.

Dr. Yerian has authored over 150 manuscripts, articles, and book chapters and is the recipient of multiple awards, including the Association of American Medical Colleges Clinical Care Innovation Challenge Award. She serves on multiple nonprofit boards and speaks nationally and internationally on leadership, culture and improvement. 
Education & Professional Highlights

Education & Professional Highlights

Appointed
2004

Education & Fellowships

Fellowship - University of Chicago Hospitals
Gastrointestinal and Liver Pathology
Chicago, IL
2004

Residency - University of Chicago Hospitals
Anatomic / Clinical Pathology
Chicago, IL
2003

Medical Education - University of Chicago Pritzker School of Medicine
MD
Chicago, IL
2000

Undergraduate - University of Notre Dame
Biology
Notre Dame, IN
1996

Certifications

  • Pathology - Anatomic Pathology

Specialty Interests

gastrointestinal pathology, Hepatic Pathology, liver and gastrointestinal pathology

Research & Publications

Research & Publications

See publications for Lisa Yerian, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/27/2023, Dr. Yerian has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Fiduciary Role. Dr. Yerian serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

  • Catalysis, Inc. 
  • Lean Enterprise Institute, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Back to Top